Search - tctmd.com

Displaying 741 - 760 of 1510

Sort: Relevancy | Date

Presentation TCT 2019

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Presenter: Elazer Edelman

September 26, 2019

Presentation TCT 2019

PERT: Why and How

Presenter: Robert Lookstein

September 26, 2019

Presentation TCT 2019

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

Presenter: Krishna Rocha-Singh

September 26, 2019

Presentation TCT 2019

New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated)

Presenter: Konstantinos Katsanos

September 26, 2019

Presentation TCT 2019

Diagnosing Pulmonary Embolism: A Practical Approach

Presenter: Ido Weinberg

September 26, 2019

Presentation TCT 2019

Preventing PE in the Cardiac Patient: What Therapies and for Whom?

Presenter: Herbert Aronow

September 26, 2019

Presentation TCT 2019

Catheter-Directed Therapy for Acute PE I: Indications, Options, Outcomes

Presenter: Vikas Aggarwal

September 26, 2019

Presentation TCT 2019

1-Year Late Lumen Loss With a Polymer-Coated Paclitaxel-Eluting Stent and a Polymer-Free Paclitaxel-Coated Stent for Femoropopliteal Disease: Study Results

Presenter: Daizo Kawasaki

September 26, 2019

Presentation TCT 2019

Optimal Vessel Preparation Evaluated by Multimodality Imaging: Results From IGNITE

Presenter: Masahiko Fujihara

September 26, 2019

Presentation TCT 2019

New Crossing Techniques for Complex Femoropopliteal Disease

Presenter: Makoto Utsunomiya

September 26, 2019

Presentation TCT 2019

Mortality Risk Following Application of Paclitaxel-Coated Devices in Femoropopliteal Lesion: Results From the CAROOT Study

Presenter: Yoshimitsu Soga

September 26, 2019

Presentation TCT 2019

Intravascular Ultrasound Supported Endovascular Therapy in SFA Disease: 12-Month Results From the IVORY Study

Presenter: Osamu Iida

September 26, 2019

Presentation TCT 2019

Introduction

Presenter: Masato Nakamura

September 26, 2019

TCT Shark Tank Innovation Competition Finalists - Endovenous Valve Formation System for Deep Vein Reflux and Severe Chronic Venous Insufficiency (Intervene Blue Leaf)

Presentation TCT 2019

Endovenous Valve Formation System for Deep Vein Reflux and Severe Chronic Venous Insufficiency (Intervene Blue Leaf)

Presenter: Fletcher Wilson

September 26, 2019

Presentation TCT 2019

Emerging Drug-Free Platforms for the SFA: Can We Do Better Off Drugs?

Presenter: William Gray

September 26, 2019

Presentation TCT 2019

Deciphering the FDA Guidance

Presenter: Mehdi Shishehbor

September 26, 2019

Presentation TCT 2019

State of the Art Lecture: Novel Drug Delivery Technologies for the SFA

Presenter: Juan Granada

September 26, 2019

Presentation TCT 2019

Introduction and Session Objectives

Presenter: Sahil Parikh

September 26, 2019

Presentation TCT 2019

My Worst Complication of the Year

Presenter: Peter Soukas

September 25, 2019

Presentation TCT 2019

My Toughest Alternative Access Case of the Year

Presenter: Robert Lookstein

September 25, 2019

Advertisement

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

PERT: Why and How

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated)

Diagnosing Pulmonary Embolism: A Practical Approach

Preventing PE in the Cardiac Patient: What Therapies and for Whom?

Catheter-Directed Therapy for Acute PE I: Indications, Options, Outcomes

1-Year Late Lumen Loss With a Polymer-Coated Paclitaxel-Eluting Stent and a Polymer-Free Paclitaxel-Coated Stent for Femoropopliteal Disease: Study Results

Optimal Vessel Preparation Evaluated by Multimodality Imaging: Results From IGNITE

New Crossing Techniques for Complex Femoropopliteal Disease

Mortality Risk Following Application of Paclitaxel-Coated Devices in Femoropopliteal Lesion: Results From the CAROOT Study

Intravascular Ultrasound Supported Endovascular Therapy in SFA Disease: 12-Month Results From the IVORY Study

Introduction

Endovenous Valve Formation System for Deep Vein Reflux and Severe Chronic Venous Insufficiency (Intervene Blue Leaf)

Emerging Drug-Free Platforms for the SFA: Can We Do Better Off Drugs?

Deciphering the FDA Guidance

State of the Art Lecture: Novel Drug Delivery Technologies for the SFA

Introduction and Session Objectives

My Worst Complication of the Year

My Toughest Alternative Access Case of the Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content